FDA Medical Acoustics Research

U.S. Food and Drug Administration (FDA)

FDA-CDRH-

9/30/2027 3:00:00 PM Eastern Time Zone

Applications will be reviewed on a rolling-basis.

A research opportunity is available within the Center for Devices and Radiological Health (CDRH), Food and Drug Administration (FDA), located at Silver Spring, Maryland.

The FDA's CDRH Medical Acoustics Program ensures safe medical acoustic devices through therapeutic/diagnostic and transcranial sub-programs covering brain treatments, tumor ablation, pain management, and cardiovascular care across all patient populations. The program addresses gaps including lack of transcranial device understanding, absence of standardized acoustic/thermal characterization methods, and insufficient computational models.

• How to investigate transcranial safety
• Development of standardized characterization methodologies and computational tools
• Creation of standard foundations for emerging technologies
• Safety assessment and standard testing approaches
• Process for the development of regulatory guidance for acoustic device applications

The mentor for this opportunity is Subha Maruvada, subha.maruvada.gov. If you have questions about the nature of the research, please contact the mentor.

2026. Start date is flexible and will depend on a variety of factors.

The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.

The appointment is full time.

The participant will receive a monthly stipend commensurate with educational level and experience.

This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded  can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.

If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate the relationship, then the individual is not placed  additional requirements, see FDA Ethics for Nonemployee Scientists.

FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers…